Anna Raunio
Impact in
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurological diseases and metabolism
- Botulinum Toxin and Related Neurological Disorders
-
- Nuclear Receptors and Signaling
- Genetic Neurodegenerative Diseases
- Nerve injury and regeneration
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 6
- Neurological diseases and metabolism 3
- Neurological disorders and treatments 2
- Cerebrovascular and genetic disorders 2
-
- Alzheimer's disease research and treatments 5
- Co-authors
- Liisa Myllykangas (12 shared papers)Anders Paetau (10 shared papers)Pentti J. Tienari (7 shared papers)Minna Pöyhönen (1 shared paper)Petra Pasanen (1 shared paper)Seppo Kaakkola (1 shared paper)Jukka Lyytinen (1 shared paper)Maija Siitonen (1 shared paper)
- Journals
- Journal of Alzheimer s Disease (2 papers)Alzheimer s & Dementia (2 papers)Neuropathology and Applied Neurobiology (1 paper)Brain (1 paper)Pediatric Blood & Cancer (1 paper)
- Partner nations
- FinlandUnited KingdomJapan
In The Last Decade
Anna Raunio
15 papers receiving 854 citations
Anna Raunio's Hit Papers
Peers
Comparison fields: 5 of 65
- Neurology 638
- Neurology 131
- Cellular and Molecular Neuroscience 217
- Physiology 259
- Immunology and Allergy 37
Countries citing papers authored by Anna Raunio
This map shows the geographic impact of Anna Raunio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Raunio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Raunio more than expected).
Fields of papers citing papers by Anna Raunio
This network shows the impact of papers produced by Anna Raunio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Raunio. The network helps show where Anna Raunio may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Raunio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology Hit paper breakdown → | 2014 | 421 |
| 2 | 2021 | 141 | |
| 3 | 2022 | 79 | |
| 4 | 2019 | 58 | |
| 5 | 2006 | 51 | |
| 6 | 2019 | 23 | |
| 7 | 2018 | 22 | |
| 8 | 2010 | 18 | |
| 9 | 2021 | 15 | |
| 10 | 2017 | 14 | |
| 11 | 2024 | 9 | |
| 12 | 2022 | 7 | |
| 13 | 2017 | 5 | |
| 14 | 2025 | 2 | |
| 15 | 2019 | 1 |
About Anna Raunio
Anna Raunio is a scholar working on Neurology, Physiology, Complementary and alternative medicine, Neurology and Molecular Biology, having authored 15 papers that have together received 866 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (6 papers), Alzheimer's disease research and treatments (5 papers), Ginkgo biloba and Cashew Applications (4 papers), Neurological diseases and metabolism (3 papers), Neurological disorders and treatments (2 papers), Cerebrovascular and genetic disorders (2 papers), Bone and Joint Diseases (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Neurology (638 citations), Neurology (131 citations), Cellular and Molecular Neuroscience (217 citations), Physiology (259 citations) and Immunology and Allergy (37 citations). Anna Raunio has collaborated with scholars based in Finland, United Kingdom and Japan. Frequent co-authors include Liisa Myllykangas, Anders Paetau, Pentti J. Tienari, Minna Pöyhönen, Petra Pasanen, Seppo Kaakkola, Jukka Lyytinen, Maija Siitonen, Shigeo Murayama and Per Borghammer. Their work appears in journals such as Journal of Alzheimer s Disease, Alzheimer s & Dementia, Neuropathology and Applied Neurobiology, Brain and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.